{
    "nctId": "NCT06509555",
    "briefTitle": "Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy",
    "officialTitle": "Establishment of Serum TK1 Combined With MRI to Predict Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms, TK1",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Correlation analysis of serum TK1 and pathological remission of breast cancer with neoadjuvant chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n\u2460 The patient was diagnosed with breast cancer by biopsy, and there were complete pathological data. \u2461 Complete the course of neoadjuvant chemotherapy; \u2462 After the end of neoadjuvant therapy, the operation was performed and the postoperative pathology was obtained; MRI and serum TK1 data were complete (baseline, after 2 cycles of chemotherapy, 4 cycles of chemotherapy, and 6 cycles of chemotherapy).\n\nExclusion Criteria:\n\n\u2460 Distant metastasis at first diagnosis (stage IV); \u2461 With other primary malignant tumors.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}